KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Treasury Shares for 2 consecutive years, with $257450.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 22.6% to $257450.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $257450.0 through Dec 2025, up 22.6% year-over-year, with the annual reading at $257450.0 for FY2025, 22.6% up from the prior year.
  • Treasury Shares for Q4 2025 was $257450.0 at Xenon Pharmaceuticals, down from $313382.0 in the prior quarter.
  • The five-year high for Treasury Shares was $313382.0 in Q3 2025, with the low at $192000.0 in Q1 2024.